New Pediatric IBD Therapies
Contact
Description
The purpose of this study is to help understand how well new IBD medications work, obtain safety information, and understand patient's quality of life while on the medications.
Eligibility and criteria
IRB Number:
23-021091
Eligible age range:
Clinical trial phase:
N/A
Official title:
What to expect
Participation will last for approximately three years per medication started. The study procedures include medical record review, one initial telephone interview, 17 periodic online questionnaires, and up to three stool sample collections for calprotectin if not done clinically.
Related specialties
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.